Ultra-LEAF™ Purified anti-human BMP-14 (GDF-5) Antibody

Pricing & Availability
Clone
A16098C (See other available formats)
Regulatory Status
RUO
Other Names
Bone morphogenetic protein 14 (BMP14), cartilage-derived morphogenetic protein 1 (CDMP1), BDA1C, Lipopolysaccharide associated protein 4 (LAP4), LPS associated protein 4, OS5, SYM1B, SYNS2, GDF5
Isotype
Mouse IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
A16098C_ULEAF_BMP-14_Antibody_012722
Recombinant human BMP-14 (GDF-5) (Cat. No. 779506) (black circles) induces the differentiation of ATDC5 mouse chondrogenic cells. Ultra-LEAF™ purified anti-human BMP-14 (GDF-5) (clone A16098C) (purple squares) inhibits the effect of recombinant human BMP-14 (GDF-5) at 1.5 µg /mL on ATDC5 cells in a dose-dependent manner, whereas the GoInVivo™ purified mouse IgG2b, κ isotype control (Cat. No. 400366) (gray triangles) does not have the effect. ND50 range: 3 – 15 μg/mL
  • A16098C_ULEAF_BMP-14_Antibody_012722
    Recombinant human BMP-14 (GDF-5) (Cat. No. 779506) (black circles) induces the differentiation of ATDC5 mouse chondrogenic cells. Ultra-LEAF™ purified anti-human BMP-14 (GDF-5) (clone A16098C) (purple squares) inhibits the effect of recombinant human BMP-14 (GDF-5) at 1.5 µg /mL on ATDC5 cells in a dose-dependent manner, whereas the GoInVivo™ purified mouse IgG2b, κ isotype control (Cat. No. 400366) (gray triangles) does not have the effect. ND50 range: 3 – 15 μg/mL
Cat # Size Price Quantity Check Availability Save
949203 100 µg £245
Check Availability


Need larger quantities of this item?
Request Bulk Quote
949204 1 mg £825
Check Availability


Need larger quantities of this item?
Request Bulk Quote

Select size of product is eligible for a 40% discount! Promotion valid until December 31, 2024. Exclusions apply. To view full promotion terms and conditions or to contact your local BioLegend representative to receive a quote, visit our webpage.

Description

Growth and differentiation factor-5 (GDF-5) was initially identified in partially purified extracts from newborn calf articular cartilage. It is part of the bone morphogenetic protein (BMP) family of proteins, which are members of the TGF-β superfamily and plays a key role in skeletal development, bone formation, and stem cell differentiation. Human GDF-5 is highly homologous to its murine equivalent and the mature proteins differ only by one amino acid. GDF-5 belongs together with GDF-6 and GDF-7 to a subfamily of the BMPs. BMPs signal through heterotetrameric complex receptors, which include four type I receptors (ALK1, ALK2, ALK3, and ALK6) and three type II receptors (BMPRII, ActRIIA, and ActRIIB). GDF-5 binds specifically to BMPR1b, BMPRII, and ACTRIIA receptors forming a heterodimeric complex thus inducing the phosphorylation of smad1, 5, 8 and the translocation to the nucleus. GDF-5 enhances endochondral bone growth, development of limb skeletons and joints, and odontogenesis. GDF-5 stimulates osteogenic differentiation and increases VEGF levels in fat-derived stromal cells in vitro. In addition, GDF-5 stimulates the proteoglycans and type II collagen production in intervertebral disc cells, and enhances cell proliferation and matrix synthesis in annulus fibrosus and nucleus pulposus cells, which inhibits degenerative disc disease. GDF-5 could be suitable for gene therapy for lumbar intervertebral disc degeneration. Mutations in the human GDF-5 gene result in a broad spectrum skeletal disorders. GDF-5 is a potent neurotrophic factor in vitro and in vivo for rat dopaminergic midbrain neurons, specifically the ones that degenerate in Parkinson's disease. Exogenous GDF-5 is neuroprotective in animal models of Parkinson’s disease. Moreover, it is a key regulator of the growth and elaboration of pyramidal cell dendrites in the developing hippocampus.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Recombinant human BMP-14 (GDF-5)
Formulation
0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative.
Endotoxin Level
Less than 0.01 EU/µg of the protein (< 0.001 ng/µg of the protein) as determined by the LAL test.
Preparation
The Ultra-LEAF™ (Low Endotoxin, Azide-Free) antibody was purified by affinity chromatography.
Concentration
The antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL. Older lots may have also been bottled at 1 mg/mL. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. This Ultra-LEAF™ solution contains no preservative; handle under aseptic conditions.
Application

Neut - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by neutralizing the differentiation induced by recombinant human BMP-14 (GDF-5) (Cat. No. 779506) at 1.5 µg/mL on ATDC5 mouse chondrogenic cells. ND50 range: 3 – 15 µg/mL. It is recommended that the reagent be titrated for optimal performance for each application.

RRID
AB_2910514 (BioLegend Cat. No. 949203)
AB_2910514 (BioLegend Cat. No. 949204)

Antigen Details

Structure
Homodimer
Distribution

Predominantly expressed in cartilaginous tissues, precartilaginous mesenchymal condensation, and throughout the cartilaginous cores of the developing long bones

Function
Skeletal development during embryogenesis, joint formation, tendon repair, and odontogenesis. MicroRNA-21 suppresses the expression of GDF-5 by inducing GDF-5 mRNA decay in chondrocytes. Noggin inhibits GDF-5.
Interaction
Chondrocytes, osteoblast, periosteum cells, fibroblasts, hippocampal pyramidal cells, and dopaminergic midbrain neurons
Ligand/Receptor
BMPR1b, BMPRII, and ACTRIIA
Cell Type
Embryonic Stem Cells, Fibroblasts, Hematopoietic stem and progenitors, Mesenchymal cells, Mesenchymal Stem Cells, Neural Stem Cells, Neurons
Biology Area
Cell Biology, Neuroscience, Stem Cells, Synaptic Biology
Molecular Family
Cytokines/Chemokines, Growth Factors
Antigen References
  1. Chang SC, et al. 1994. J Biol Chem. 269:28227-34.
  2. Hotten G, et al. 1994. Biochem Biophys Res Commun. 204:646-52.
  3. Nishitoh H, et al. 1996. J Biol Chem. 271:21345-52.
  4. Groppe J, et al. 2002. Nature. 420:636-42.
  5. Chen X, et al. 2006. J Mol Cell Cardiol. 41:26-33.
  6. Kleinschmidt K, et al. 2013. Biomaterials. 34:5926-36.
  7. Osorio C, et al. 2013. Development. 140:4751-62.
  8. Zhang Y, et al. 2014. Exp Mol Med. 46:e79.
  9. Li YF, et al. 2015. Int J Clin. Exp Pathol. 8:719-26.
Gene ID
8200 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
BMP-14
Specificity Alt (DOES NOT SHOW ON TDS):
BMP-14
App Abbreviation (DOES NOT SHOW ON TDS):
Neut
UniProt
View information about BMP-14 on UniProt.org

Related FAQs

Do you guarantee that your antibodies are totally pathogen free?

BioLegend does not test for pathogens in-house aside from the GoInVivo™ product line. However, upon request, this can be tested on a custom basis with an outside, independent laboratory.

Does BioLegend test each Ultra-LEAF™ antibody by functional assay?

No, BioLegend does not test Ultra-LEAF™ antibodies by functional assays unless otherwise indicated. Due to the possible complexities and variations of uses of biofunctional antibodies in different assays and because of the large product portfolio, BioLegend does not currently perform functional assays as a routine QC for the antibodies. However, we do provide references in which the antibodies were used for functional assays and we do perform QC to verify the specificity and quality of the antibody based on our strict specification criteria.

Does BioLegend test each Ultra-LEAF™ antibody for potential pathogens?

No, BioLegend does not test for pathogens in-house unless otherwise indicated.  However, we can recommend an outside vendor to perform this testing as needed.

Have you tested this Ultra-LEAF™ antibody for in vivo or in vitro applications?

We don't test our antibodies for in vivo or in vitro applications unless otherwise indicated. Depending on the product, the TDS may describe literature supporting usage of a particular product for bioassay. It may be best to further consult the literature to find clone specific information.

Go To Top Version: 1    Revision Date: 01/27/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account